Литература
1. Stratton I.M., Adler A.I., Neil H.A. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes [UKPDS 35]: prospective observational study // BMJ. - 2000. - Vol. 321. - P. 405-412.
2. Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients / Capone R.J., Pawitan N. // J. Am. Coll. Cardiol. - 1991. - Vol. 18. - P. 1434-1458.
3. Нарушение ритма и проводимости сердца у больных с гипертонической болезнью и сопутствующим сахарным диабетом 2 типа / Л.В. Масляева, Т.Г. Старченко// Материалы первого всероссийского съезда аритмологов. - М., 2005. - С. 72-74.
4. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community / C.J. Osgren et al. // Obes. Metab. - 2004. - Vol. 6, N 5. - P. 367-374.
5. Аритмологичкая характеристика больных с хронической сердечной недостаточностью при сохраненном синусовом ритме и подход к ее улучшению / И.В. Нестерова и др. // Вестник аритмологии. - 2003. - № 31. - С. 20-25.
6. Heart failure in patients seeking medical help in outpatients clinics. Pt I. General characteristics / S.L. Rywik et al. // Eur. J. Heart Fail. - 2000. - Vol. 2, N 4. - P. 413-421.
7. Сравнительная оценка эпизодов ишемии миокарда и нарушения ритма сердца по результатам суточного мониторирования ЭКГ у пациентов с гипертонической болезнью и сочетанием гипертонической болезни с инсулиннезависимым сахарным диабетом / А.Д. Измайлов, Е.Ю. Коломин, Р.С. Карпов // Вестник аритмологии. - 2000. - № 3. - С. 21-25.
8. Особенности гисто- и ультраструктурной организации миокарда и стенки сосудов у больных с сахарным диабетом типа 2 / А.Л. Давыдов, Л.Ю. Баранова // Проблемы эндокринологии. - 2005. - № 3. - С. 33-38.
9. Внезапная коронарная смерть / Н.А. Николаев и др. // Сердце. - 2006. - Т. 5б № 5. - С. 265-267.
10. Risk factors in coronary atherosclerosis athero-inflammation // Thromb. J. - 2003. - Vol. 1, N 1. - P. 4.
11. Detection and management of lipid disorders in diabetes. American Diabetes Association // Diabetes Care. - 1993. - Vol. 16, N 5. - P. 828-834.
12. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in Framingham Hear Study / M.K. Rutter et al. // Circulation. - 2003. - Vol. 107. - P. 448-454.
13. Мерцательная аритмия: новый лик сахарного диабета в XXI веке / А.А. Александров, М.Н. Ядрихинская, С.С. Кухаренко // Сахарный диабет. - 2011. - № 1. - C. 53-60.
14. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease // Bratis. Lek. Listy. - 2000. - Vol. 101, N 10. - P. 541-551.
15. Kern W., Peters A., Born J. et al. Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia // Metabolism. - 2005. - Vol. 54. - P. 391-396.
16. Coutinho M., Genstein H.C. The relationship between glucose and incident cardiovascular events; met regression analysis of published data from 20 studies of 95783 individuals followed for 12,4 years // Diabetes Care. - 1999. - P. 233-240.
17. UK Prospective Diabetes Study [UKPDS] Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes [UKPDS 34] // Lancet. - 1998. - Vol. 352. - P. 854-865.
18. Nathan D.M., Cleary P.A., Backlund J.Y. et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes // N. Engl. J. Med. - 2005. - Vol. 353. - P. 2643-2653.
19. Patel A., MacMahon S., Chalmers J. et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes // N. Engl. J. Med. - 2008. - Vol. 358. - P. 2560-2572.
20. Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus - a randomized prospective 6-year study // Diabetes Res. Clin. Pract. - 1995. - Vol. 28. - P. 103-117.
21. UK Prospective Diabetes Study [UKPDS] Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes [UKPDS 33] // Lancet. - 1998. - Vol. 352. - P. 837-853.
22. Bagg W. Cardiac and endothelial function is unaffected by shortterm intensive glycaemic control in patients with type-2 diabetes mellitus [abstract] // Int. Med. J. - 2001. - Vol. 31. - P. A1.
23. Abraira C., Colwell J.A., Nuttall F.Q. et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes [VA CSDM]: results of the feasibility trial // Diabetes Care. - 1995. - Vol. 18. - P. 1113-1123.
24. NICA-SUGAR Study Investigators, Finfer S., Chittock D.R., Su S.Y. et al. Intensive versus conventional glucose control in critical ill patients // N. Engl. J. Med. - 2009. - Vol. 360. - P. 1283-1297.
25. Low fasting plasma glucose levels as a predictor of cardiovascular disease and all-cause mortality // Circulation. - 2000. - Vol. 101. - P. 2047-2052.
26. Keen H. The Diabetes Control and Complications Trial [DCCT]. Health Trends 1994; 26:41-43. Hypoglycemia in the Diabetes Control and Complications trial. The Diabetes Control and Complications Trial Research Group // Diabetes. - 1997. - Vol. 46. - P. 271-286.
27. Duckworth W., Abraira C., Moritz T. et al., VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes // N. Engl. J. Med. - 2009. - Vol. 360. - P. 129-139.
28. BARI2D Study Group, Frve R.L., August P., Broocs M.M., Hardison R.M., Kelsev S.F., Mac Gregor J.M., Orhard T.J., Chaitman
29. Mellbin L.G., Malmberg K., Waldenstrom A. et al., DIGAMI 2 Investigators [Prognosis implications of hypoglycaemic episodes during hospitalization for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial // Heart. - 2009. - Vol. 95. - P. 721-727.
30. Investigating the dual nature of endothelin-1: ischemia or direct arrhethmogenic effect? / T. Szabo, B. Merkely // Life Sci. - 2000. - Vol. 66, N 26. - P. 2527-2541.
31. Dead in bed syndrome - a hypothesis // Diabetes Obes. Metab. - 2006. - Vol. 8. - P. 261-263. Bell
32. Influence of autonomic neuropathy on QT interval lengthening during hypoglycemia in type 1 diabetes / S.P. Lee et al. // Diabetes. - 2004. - Vol. 53. - P. 1535-1542.
33. Cardiac Sympathetic Disinnervation in Diabetes / M.J. Stevens, M.R. David, K.C. Allman // Circulation. - 1998. - Vol. 98. - P. 961-968.
34. Metabolic disturbances in diabetic cardiomyopathy / B. Rodrigues, M.C. Cam, J.H. McNeill // Mol. Cell. Biochem. - 1998. - Vol. 180, N 1-2. - P. 53-57.
35. Altered acecetylcholine and norepinephrine concentrations in diabetics rat hearts/ N. Akiyama, K. Okumura, Y. Watanabe // Diabetes. - 1989. - Vol. 38. - P. 231-236.
36. Increased plasma lavels of endothelin 1 and von Willebranda factor in patients with type 2 diabetes and dyslipiemia / B.G. Seligman, A. Biolo, C.A. Polanczuk // Diabetes Care. - 1997. - Vol. 23, N 9. - P. 1395-1400.
37. Gill G.V., Woodward A., Casson I.F., Weston P.J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes - the "dead in bed" syndrome revisited // Diabetologia. - 2009. - Vol. 52. - P. 42-45.
38. Электорокардиографические маркеры риска внезапной смерти. Влияние ишемии и реваскуляризации миокарда / А.Э Радзевич, А.С. Сметнев, В.В. Попов и др. // Кардиология. - 2001. - № 6. - C. 99-104.
39. Puljevic D., Smalclj A., Duracovic Z. QT dispersion, daily variations, and late potentials as risk markers for ventricular tachycardia // Eur. Heart J. - 1997. - Vol. 18, N 6. - P. 1343-1349.
40. Robinson R.T., Harris N.D., Ireland R.H. et al. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes // Diabetologia. - 2004. - Vol. 47. - P. 12-315.
41. Puljevic D., Smalclj A., Duracovic Z. QT dispersion, daily variations, and late potentials as risk markers for ventricular tachycardia // Eur. Heart J. - 1997. - Vol. 18, N 6. - P. 1343-1349.
42. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction [DIGAMI study]: effects on mortality at 1 year // Am. Coll. Cardiol. - 1995. - Vol. 26. - P. 57-65.
43. Sawicki et al., Christensen et al. Christensen P.K., Gall M.A., MajorPedersen A., Sato A., Rossing P., Breum L., Pietersen A., Kastrup J., Parving H.H. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes // Scand. J. Clin. Lab. Invest. - 2000. - Vol. 60. - P. 323-332.
44. Sawicki P.T., Kiwitt S., Bender R., Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin dependent diabetes mellitus // J. Intern. Med. - 1998. - Vol. 243. - P. 49-56.
45. Davidson N.C., Darbar D., Luck J. et al. QT interval dispersion predicts cardiac death in patients with peripheral vascular disease // Br Heart J. - 1995. - Vol. 73.
46. Interlead QT variability as measure of temporal dispersion of ventricular recovery / Day C.P. // Br. Heart J. - 1990. - Vol. 64. - P. 81-82.
47. Okin PM, Devereux R.B., Lee E.T. et al. Electrocardiographic repolarisation complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study // Diabetes. - 2004. - Vol. 53, N 2. - P. 434-440.
48. Наn J., Moe G. Nonuniform recovery of exitability in ventricular muscle // Circ. Res. - 1964. - Vol. 14. - P. 44-60.
49. Comparison of QTc interval in diabetics with and without neuropathy and healthy normal volunteers / V. Salvi, P. Hingorani, V. Mahajan et al. // Indian Heart J. - 2007. - Vol. 58. - P. 418-423.
50. Epidemiological Evidence of Altered Cardiac Autonomic Function in Subjects with Impaired Glucose Tolerance But Not Isolated Impaired Fasting Glucose / J.S. Wu, Y.C. Yang , T.S. Lin et al. // J. Clin. Endocrinol. Metab. - 2007. - Vol. 92. - P. 3885-3889.
51. QT interval, Cardiovascular risk factors and risk of death in diabetes / M. Veglio, A. Chinaglia, P. Cavallo-Perin // J. Endocrinol. Invest. - 2004. - Vol. 27, N 2. - P. 175-181.
52. Особенности гисто- и ультраструктурной организации миокарда и стенки сосудов у больных с сахарным диабетом типа 2 / А.Л. Давыдов, Л.Ю. Баранова // Проблемы эндокринологии. - 2005. - № 3. - С. 33-38.
53. Giunti S., Fornengo P. et al. Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic Subjects. The population-based Casale Monferrato Study // Diabetes Care. - March 2012. - Vol. 35, N 3. - P. 581-583.
54. Carrick W.A., Moore R.D., Thompson R.C. Effect of insulin upon membrane bound [Na+ K+] - ATPase extracted from frog skeletal muscle // J. Physiol. - 1975. - Vol. 252, N 1. - P. 43-58. Golfman L., Dixon I.M., Takeda N. in rats. // Mol. Cell Biochem. - Vol. 188. - P. 91-101.
55. Yue D.T., Herzig S., Marban E. Beta-adrenergetic stimulation of calcium channes occurs by potentiation of high-activity gating models // Proc. Natl Acad. Sci. USA. - 1990. - Vol. 87, N 2. - P. 753-757.
56. Robinson R.T., Harris N.D., Ireland R.H. et al. Mechanisms of abnormal cardiac repolarisation during insulin-induced hypoglycemia of abnormal cardiac repolarization insulininduced hypoglycemia // Diabetes. - 2003. - Vol. 52. - P. 1469-1474.
57. Hillebrand S., Gast K.B., de Mutsert R. et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression // Europace. - 2013. - Jan. 30
58. Lombardi F. Chaos Theory Heart Rate Variability, and Arrhythmic Mortality // Circulation. - 2000. - Vol. 101. - P. 8-10.
59. Kleiger R.E., Miller J.P., Bigger J.T., Moss A.J., The Multi-Center Postinfarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction // Am. J. Cardiol. - 1987. - Vol. 59. - P. 256-252.
60. Domanski M.J., Exner D.V., Borkowf C.B. et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials // J. Am. Coll. Cardiol. - 1999. - Vol. 33. - P. 598-604.
61. Сoutinho M., Gerstein H.C., Wang Y., Yusuf S.The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years // Diabetes Care. - 1999. - Vol. 22. - P. 233-240.
62. Barr E.L., Zimmer P.Z., Welborn T.A. et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study [AusDiab] // Circulation. - 2007. - Vol. 116. - P. 151-157.
63. Barr E.L., Boyko E.J., Zimmer P.Z. et al. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle [AusDiab] study // Diabetologia. - 2009. - Vol. 52. - P. 415-424.
64. Risk factors for myocardial infarction and deth in newl detected NIDDM; the Diabetes International Study, 11-year follow-up / M. Henefeld et al. // Diabetologia. - 1996. - Vol. 39, N 12. - P. 1577-1583.
65. Service F.J., O’Brien P.C. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial // Diabetologia. - 2001. - Vol. 44. - P. 1215-1220.
66. Tominaga M., Eguchi H., ManaKa H. et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study // Diabetes Care. - 1999. - Vol. 22. - P. 920-924.
67. The DECODE study group; European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe // Lancet. - 1999.
68. Nakagami T., DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin // Diabetologia. - 2004. - Vol. 47. - P. 385-394.
69. Holman R.R., Haffner S.M., Murray J.J. et al., NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events // N. Engl. J. Med. - 2010. - Vol. 362. - P. 1463-1476. Raz I., Wilson P.W.F., Strojek K. et al. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial // Diabetes Care. - 2009. - Vol. 32. - P. 381-386.
70. Chiasson J.L., Josse R.G., Gomis R. et al., STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial // JAMA. - 2003. - Vol. 290. - P. 486-494.
71. Кrinsley J.S. Glycemic variability: a strong independent predictor of mortality in critically ill patients // Crit. Care Med. - 2008. - Vol. 36. - P. 3008-3013.
72. Variability of blood glucose concentration and short-term mortality in critically ill patients // Anesthesilogy. - 2006. - Vol. 105. - P. 244-252. Egi M., Bellomo R., Stachowski E., French C.J., Hart G..
73. Azuma K., Watada H., Niihashi M. A new En face method is useful to quantitate endothekial damage in vivo // Biochem. Biophys. Res. Commun. - 2003. - Vol. 309. - P. 384-390.
74. Azuma K., Kowamori R., Toyofuku Y. et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta // Arteriscler. Thromb. Vasc. Biol. - 2006. - Vol. 26. - P. 2275-2280.
75. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients / A. Ceriello et al. // Diabetes. - 2008. - Vol. 57, N 5. - P. 1349-1354.
76. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients / A. Ceriello et al. // Diabetes. - 2008. - Vol. 57, N 5. - P. 1349-1354.
77. Ihnat M.A., Kaltreider R.C., Thorpe J.E. Attenuated superoxide dismutase induction in retinal cells in response to intermittent high versus continuous high glucose // Am. J. Biochem. Biotech. - 2007. - Vol. 3. - P. 16-23.
78. Ceriello A., Morocutti A., Mercuri F. et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy // Diabetes. - 2000. - Vol. 49. - P. 2170-2177.
79. Meugnier E., Faraj M., Rome S. et al. Acute hyperglycemia induces a global down regulation of gene expression in adipose tissue and skeletal muscle of healthy subjects // Diabetes. - 2007. - Vol. 56. - P. 992-999.
80. The effect of glucose variability on the risk of miocrovasculr complications in type 1 diabetes / E.S. Kilpatrick, A.S. Rigby, S.L. Atkin // Diabetes Care. - 2006. - Vol. 29, N 7. - P. 1486-1490.
81. Esposito K., Nappo F., Marfella R. et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress // Circulation. - 2002. - Vol. 106. - P. 2067-2072. pmid:12379575
82. Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is it important? How to Measure it? / L. Monnier et al. // J. Diabetes Sci. Technol. - 2008. - Vol. 2, N 6. - P. 1094-1100.
83. Prospective study of heart rate variability and mortality in chronic heart failure : Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial [UK-Heart]/J. Nolan et al. // Circulation. - 1998. - Vol. 98, N 15. - P. 1510-1516.
84. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI [Autonomic Tone and Reflexes After Myocardial Infarction ] Investigators / M.T. La Rovere et al. // Lancet. - 1998. - Vol. 351, N 9101. - P. 478-484.
85. Dead in bed syndrome - a hypothesis // Diabetes Obes. Metab. - 2006. - Vol. 8. - P. 261-263.
86. Influence of autonomic neuropathy on Qtc interval lengthening during hypoglycemia in type 1 diabetes / S.P. Lee et al. // Diabetes. - 2004. - Vol. 53. - P. 1535-1538.
87. Ventricular arrhythmias associated with hypoglycaemia // Anaesth. Intensive Care. - 2000. - Vol. 28, N 6. - P. 698-700.
88. Диабетическая автономная нейропатия / И.А. Бондарь, О.Ю. Шабельникова // Сахарный диабет. - 2009. - № 4. - С. 52-55.
89. Vascular risk factors and diabetic neuropathy / S. Tesfaye et al. // N. Engl. J. Med. - 2005. - Vol. 352, N 4. - P. 341-350.
90. Heart rhythm, ventricular arrhythmias, and death in chronic heart failure / P. Ponikowski et al. // J. Card. Fail. - 1996. - Vol. 2, N 3. - P. 177-183.
91. Vascular risk factors and diabetic neuropathy / S. Tesfaye et al. // N. Engl. J. Med. - 2005. - Vol. 352, N 4. - P. 341-350. Heart rate variability and cardic failure / F. Lombardi, A. Mortara // Heart. - 1998. - Vol. 80. - P. 214-231.
92. Heart rate variability and cardiac failure / F. Lombardi, A. Mortara // Heart. - 1998. - Vol. 80. - P. 214-231.
93. The role of cardiac autonomic function in hypertension and cardiovascular disease / P. Palatini, P. Julius, S .Julius // Curr. Hypertens. Rep. - 2009. - Vol. 11, N 3. - P. 199-205.
94. Клиническое значение оценки вариабельности ритма сердца / Соколов С.Ф., Малкина Т.А. // Сердце. - 2002. - № 2. - С. 72-75.
95. Clinical and demographic determinants of heart rate variability in patients post myocardial infarction in sing from the cardiac arrhythmia suppression trial / P.K. Stien, P.P. Domitrovich, R.E. Kleiger et al. // Clin. Cardiol. - 2000. - Vol. 23. - P. 187-194.
96. QT dispersion in type 2 diabetes patients with altered diurnal blood pressure rhythm // Diabetes Obes. Metab. - 2005. - Vol. 7, N 2. - P. 136-143.
97. Суточное мониторирование артериального давления в клинической практике / Л.Г. Ратова, В.В. Дмитриев, С.Н. Топтыгина, И.Е. Чазова // Consilium Medicum. - 2001. - C. 3-14.
98. Взаимосвязь показателей суточного профиля артериального давления и вариабельности ритма сердца у больных артериальной гипертензией и инсулиннезависимым сахарным диабетом / Н.Н. Боровков, Н.В. Сидорова // Клиническая медицина. - 2002. - № 7. - С. 19-21.
99. Diabetic neuropathies:a statement by the American Diabetes Association / A.J. Boulton et al. // Diabetes Care. - 2005. - Vol. 28. - P. 956-962.
100. Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study / T. Koskinen et al. // Diabet. Med. - 2009. - Vol. 26, N 4. - P. 354-361.
101. Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normolbuminuric, normotensive patients with type 2 diabetes mellitus / Y.K. Kim et al. // J. Korean Med. Sci. - 2009. - Vol. 24. - P. S69-S74.